Clonal Hematopoiesis After CAR19 Therapy

Company Hamilton laboratory (academic) Event Type Peer-reviewed publication Modality CD19 CAR-T (safety biology) Asset CAR19 therapy (clonal hematopoiesis analysis) Target CD19 Disease Area Large B-cell lymphoma Summary A peer-reviewed Nature Genetics study published online November 2 links clonal hematopoiesis (CH), interferon-associated marrow inflammation, and prolonged…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *